Skip to search formSkip to main content

gadofosveset trisodium

The trisodium salt form of gadofosveset, an injectable, intravascular, amphiphilic gadolinium-based contrast agent (GBCA) used with magnetic… Expand
National Institutes of Health

Related topics

Related topics

7 relations

Broader (4)

Contrast MediaGadoliniumOrganometallic Compoundsgadofosveset

Narrower (2)

MS 325Vasovist
gadofosveset trisodium 244 MILLIGRAM In 1 MILLILITER INTRAVENOUS INJECTION [Vasovist]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
3.0-T whole-heart coronary magnetic resonance angiography: comparison of gadobenate dimeglumine and gadofosveset trisodium
Gadolinium enhanced coronary magnetic resonance angiography (MRA) at 3 T appears to be superior to non-contrast methods… Expand
  • table 2
  • table 1
  • table 3
  • table 4
  • table 5
Is this relevant?
2012
2012
Magnetic resonance VIBE venography using the blood pool contrast agent gadofosveset trisodium--an interrater reliability study.
PURPOSE In this study, image quality of leg veins and vena cava inferior was scored by independent raters using the new… Expand
Is this relevant?
2012
2012
Towards Endometriosis Diagnosis by Gadofosveset-Trisodium Enhanced Magnetic Resonance Imaging
Endometriosis is defined as the presence of endometrial tissue outside the uterus. It affects 10-15% of women during reproductive… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
Gadofosveset trisodium-enhanced abdominal perforator MRA.
PURPOSE To compare image quality including the number of perforators visualized, vessel contrast ratios, and vessel sharpness… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
2012
2012
Gadofosveset trisodium in the investigation of focal liver lesions in noncirrhotic liver: Early experience.
PURPOSE To investigate enhancement of hepatic lesions with gadofosveset trisodium (Gdfos) (Ablavar) (blood pool agent) compared… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: comparison of gadobenate dimeglumine and gadofosveset trisodium.
RATIONALE AND OBJECTIVES Dedicated contrast agents are now available for contrast-enhanced magnetic resonance angiography (CE-MRA… Expand
Is this relevant?
2010
2010
Gadobenate dimeglumine and gadofosveset trisodium for MR angiography of the renal arteries: Multicenter intraindividual crossover comparison.
OBJECTIVE This prospective multicenter intraindividual crossover study was designed to compare gadobenate dimeglumine and… Expand
  • table 1
  • figure 1—62
  • table 4
  • figure 2—73
Is this relevant?
2010
2010
Gadofosveset trisodium-enhanced magnetic resonance angiography of the left atrium--a feasibility study.
AIM Imaging of the left atrium is regularly performed prior to pulmonary vein isolation. The aim of the study was to evaluate the… Expand
  • figure 3
  • table 1
Is this relevant?
2007
2007
First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine.
OBJECTIVES To evaluate gadofosveset trisodium for first-pass magnetic resonance angiography (MRA) in the setting of whole-body… Expand
Is this relevant?
2003
2003
MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trial.
PURPOSE To evaluate the dose response and safety of gadofosveset trisodium-enhanced magnetic resonance (MR) angiography compared… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE